Robin Goldman-Leikin
-
- Monoclonal and Polyclonal Antibodies Research 9
- Radiopharmaceutical Chemistry and Applications 3
-
- Lymphoma Diagnosis and Treatment 3
-
- T-cell and Retrovirus Studies 2
- Immunotoxicology and immune responses 1
-
- Glycosylation and Glycoproteins Research 3
-
- Cutaneous lymphoproliferative disorders research 2
-
- Nanoparticle-Based Drug Delivery 1
- Co-authors
- Steven T. RosenAline ZimmerRobert J. MarderEdward H. KaplanMark S. DykewiczDaina VariakojisLeo I. GordonAntonia M. H. Piergies
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Oncology (1 paper)Annals of Emergency Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Robin Goldman-Leikin
12 papers receiving 320 citations
Peers
Comparison fields: 5 of 49
- Radiology, Nuclear Medicine and Imaging 205
- Pathology and Forensic Medicine 100
- Oncology 100
- Immunology 72
- Hematology 32
Countries citing papers authored by Robin Goldman-Leikin
This map shows the geographic impact of Robin Goldman-Leikin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Goldman-Leikin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Goldman-Leikin more than expected).
Fields of papers citing papers by Robin Goldman-Leikin
This network shows the impact of papers produced by Robin Goldman-Leikin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Goldman-Leikin. The network helps show where Robin Goldman-Leikin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robin Goldman-Leikin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 4 | |
| 2 | 1989 | 18 | |
| 3 | 1989 | 1 | |
| 4 | Characterization of a novel myeloma cell line, MM.1. | 1989 | 45 |
| 5 | 1988 | 0 | |
| 6 | Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis. | 1988 | 48 |
| 7 | Long-term persistence of human anti-murine antibody responses following radioimmunodetection and radioimmunotherapy of cutaneous T-cell lymphoma patients using 131I-T101. | 1988 | 11 |
| 8 | Human T-cell lymphotropic virus type I-associated adult T-cell leukemia/lymphoma in an atypical host. | 1987 | 4 |
| 9 | 1987 | 148 | |
| 10 | 1986 | 26 | |
| 11 | 1985 | 8 | |
| 12 | 1985 | 8 | |
| 13 | 1983 | 18 |
About Robin Goldman-Leikin
Robin Goldman-Leikin is a scholar working on Radiology, Nuclear Medicine and Imaging, Dermatology and Immunology, having authored 13 papers that have together received 339 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Glycosylation and Glycoproteins Research (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Lymphoma Diagnosis and Treatment (3 papers), T-cell and Retrovirus Studies (2 papers), Cutaneous lymphoproliferative disorders research (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Immunotoxicology and immune responses (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (205 citations), Pathology and Forensic Medicine (100 citations) and Oncology (100 citations). Robin Goldman-Leikin has collaborated with scholars based in United States. Frequent co-authors include Steven T. Rosen, Aline Zimmer, Robert J. Marder, Edward H. Kaplan, Mark S. Dykewicz, Daina Variakojis, Leo I. Gordon, Antonia M. H. Piergies, Erwin Goldberg and Michelle M. Le Beau. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Annals of Emergency Medicine, Laboratory Medicine and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.